High-dose intravenous immunoglobulins in thrombopenic purpura associated with human immunodeficiency virus infection
Castaño Caraledo, M.J.; Camps García, M.T.; Gómez Trujillo, F.; de Ramón Garrido, E.
Medicina Clinica 94(6): 236
1990
ISSN/ISBN: 0025-7753 PMID: 2329859 Document Number: 357932
Document emailed within 1 workday
Related Documents
Clauvel, J.P.; Janvier, M. 1983: Treatment of chronic idiopathic thrombopenic purpura with intravenous immunoglobulins Presse Medicale 12(41): 2640El-Ghazzawi, E.; Drew, L.; Hamdy, L.; El-Sherbini, E.; Sadek, S.e.-D.; Saleh, E. 1995: Intravenous drug addicts: a high risk group for infection with human immunodeficiency virus, hepatitis viruses, cytomegalo virus and bacterial infections in Alexandria Egypt Journal of the Egyptian Public Health Association 70(1-2): 127-150
Frésard, A.; Vindimian, M.; Genin, C.; Le Petit, J.C.; Pozzetto, B.; Lucht, F. 1994: Immunoglobulins e and human immunodeficiency virus infection (HIV) Pathologie-Biologie 42(8): 750-753
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Hollak, C.E.; Kersten, M.J.; van der Lelie, J.; Lange, J.M. 1990: Thrombocytopenic purpura as first manifestation of human immunodeficiency virus type I (HIV-1) infection Netherlands Journal of Medicine 37(1-2): 63-68
Wu, N.; Li, D.; Zhu, B.; Zou, W. 2003: Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users Chinese Medical Journal 116(9): 1318-1320
Yamada, R.; Sasagawa, T.; Kirumbi, L.W.; Kingoro, A.; Karanja, D.K.; Kiptoo, M.; Nakitare, G.W.; Ichimura, H.; Inoue, M. 2008: Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection Journal of Medical Virology 80(5): 847-855
Ruta, S.M.; Matusa, R.F.; Sultana, C.; Manolescu, L.; Kozinetz, C.A.; Kline, M.W.; Cernescu, C. 2005: High prevalence of hepatitis B virus markers in Romanian adolescents with human immunodeficiency virus infection Medgenmed: Medscape General Medicine 7(1): 68
Corti, M.E.; Palmieri, O.J.; Villafañe, M.F.; Trione, N. 2004: Evaluation of 61 episodes of infective endocarditis in intravenous drug abusers and human immunodeficiency type-1 virus infection Revista Argentina de Microbiologia 36(2): 85-87
Fain, O.; Eclache, V.; Sitbon, M.; Thomas, M. 1996: Aseptic meningitis during treatment with high-dose intravenous immunoglobulins Presse Medicale 25(13): 643
Franke, M.F.; Stulac, S.N.; Rugira, I.H.; Rich, M.L.; Bucyibaruta, J.B.; Drobac, P.C.; Iyamungu, G.; Bryant, C.M.; Binagwaho, A.; Farmer, P.E.; Mukherjee, J.S. 2011: High human immunodeficiency virus-free survival of infants born to human immunodeficiency virus-positive mothers in an integrated program to decrease child mortality in rural Rwanda Pediatric Infectious Disease Journal 30(7): 614-616
Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22
Sasaki, A.; Furukawa, Y.; Inoue, T.; Yamane, T.; Sannomiya, Y.; Im, T.; Tatsumi, N. 1989: One-day intravenous therapy with high-dose gamma-globulin for idiopathic thrombocytopenic purpura Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 52(1): 147-149
Lin, W.-C.; Lin, H.-H.; Lee, S.S.-J.; Sy, C.-L.; Wu, K.-S.; Chen, J.-K.; Tsai, H.-C.; Chen, Y.-S. 2016: Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country Journal of Microbiology Immunology and Infection 49(5): 729-736
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Rahman, M.; Sasagawa, T.; Yamada, R.; Kingoro, A.; Ichimura, H.; Makinoda, S. 2011: High prevalence of intermediate-risk human papillomavirus infection in uterine cervices of Kenyan women infected with human immunodeficiency virus Journal of Medical Virology 83(11): 1988-1996
De Vita, S.; D'Ascanio, A.; Bombardieri, S. 1991: Use of high-dose intravenous immunoglobulins in the therapy of connectivitis: preliminary experience in 5 cases Recenti Progressi in Medicina 82(11): 603-606
Willerford, D.M.; Bwayo, J.J.; Hensel, M.; Emonyi, W.; Plummer, F.A.; Ngugi, E.N.; Nagelkerke, N.; Gallatin, W.M.; Kreiss, J. 1993: Human immunodeficiency virus infection among high-risk seronegative prostitutes in Nairobi Journal of Infectious Diseases 167(6): 1414-1417
Flores-Castañeda, M.S.; Salinas-Carmona, M.C.; Yáñez-Rodríguez, A. 1991: Immunoelectroblotting in Mexican subjects at high risk for infection with human immunodeficiency virus (HIV) Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 43(3): 229-233
Guaschino, R.; Alesso, D.; Olliaro, P.; Mazzucco, L. 1985: Plasma-exchange plus high-dose intravenous gamma globulin for chronic thrombocytopenic purpura International Journal of Artificial Organs 8(3): 169